Bristol Myers Squibb (CELG-RI) Net Margin Growth (5y) (2014 - 2026)

Bristol Myers Squibb (CELG-RI) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 561.00
Dec 31, 2025 9,982.00
Sep 30, 2025 82.00
Jun 30, 2025 1,214.00
Mar 31, 2025 2,970.00
Dec 31, 2024 1,522.00
Sep 30, 2024 -1,125.00
Jun 30, 2024 -795.00
Mar 31, 2024 -12,766.00
Dec 31, 2023 -291.00
Sep 30, 2023 -1,403.00
Jun 30, 2023 1,358.00
Mar 31, 2023 -662.00
Dec 31, 2022 6,244.00
Sep 30, 2022 54.00
Jun 30, 2022 -353.00
Mar 31, 2022 -1,753.00
Dec 31, 2021 591.00
Sep 30, 2021 -853.00
Jun 30, 2021 -1,260.00